Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology

Human Genetics

Volumn 134, Issue 6, 2015, Pages 511-538

  Tesson, Christelle ^a   Koht, Jeanette ^b   Stevanin, Giovanni ^a,c  

^a SORBONNE UNIVERSITÉ   (France)

^b Vestre Viken Health Trust   (Norway)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON; GENE LOCUS; GENETIC DISORDER; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; PARAPLEGIA; PATHOLOGY;

CYTOSKELETON; GENETIC DISEASES, INBORN; GENETIC LOCI; HUMANS; LIPID METABOLISM; PARAPLEGIA;

EID: 84939944076     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-015-1536-7     Document Type: Review

References (210)

1. Abou Jamra R, Philippe O, Raas-Rothschild A et al (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88:788–795. doi:10.1016/j.ajhg.2011.04.019
2. Ajit Bolar N, Vanlander AV, Wilbrecht C et al (2013) Mutation of the iron-sulfur cluster assembly gene IBA57 cause severe myopathy and encephalopathy. Hum Mol Genet 22:2590–2602
3. Alazami AM, Adly N, Al Dhalaan H, Alkuraya FS (2011) A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). Neurogenetics 12:333–336. doi:10.1007/s10048-011-0291-8
4. Al-Saif A, Bohlega S, Al-Mohanna F (2012) Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol 72:510–516. doi:10.1002/ana.23641
5. Anheim M, Lagier-Tourenne C, Stevanin G et al (2009) SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol 256:104–108. doi:10.1007/s00415-009-0083-3
6. Antonicka H, Ostergaard E, Sasarman F et al (2010) Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. Am J Hum Genet 87:115–122. doi:10.1016/j.ajhg.2010.06.004
7. Arnoldi A, Crimella C, Tenderini E et al (2012) Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clin Genet 81(2):150–157. doi:10.1111/j.1399-0004.2011.01624.x
8. Atorino L, Silvestri L, Koppen M et al (2003) Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J Cell Biol 163:777–787. doi:10.1083/jcb.200304112
9. Barbosa MD, Barrat FJ, Tchernev VT et al (1997) Identification of mutations in two major mRNA isoforms of the Chediak–Higashi syndrome gene in human and mouse. Hum Mol Genet 6:1091–1098
10. Bauer P, Leshinsky-Silver E, Blumkin L et al (2012) Mutation in the AP4B1 gene cause hereditary spastic paraplegia type 47 (SPG47). Neurogenetics 13:73–76. doi:10.1007/s10048-012-0314-0
11. Beetz C, Nygren AOH, Schickel J et al (2006) High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67:1926–1930. doi:10.1212/01.wnl.0000244413.49258.f5
12. Beetz C, Schüle R, Deconinck T et al (2008) REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain 131:1078–1086. doi:10.1093/brain/awn026
13. Beetz C, Pieber TR, Hertel N et al (2012) Exome sequencing identifies a REEP1 mutation involved in distal hereditary motor neuropathy type V. Am J Hum Genet 91:139–145. doi:10.1016/j.ajhg.2012.05.007
14. Beetz C, Johnson A, Schuh AL et al (2013) Inhibition of TFG function causes hereditary axon degeneration by impairing endoplasmic reticulum structure. Proc Natl Acad Sci 110:5091–5096. doi:10.1073/pnas.1217197110
15. Bettencourt C, Morris HR, Singleton AB et al (2013) Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to l-DOPA treatment. J Neurol 260:2414–2416. doi:10.1007/s00415-013-7044-6
16. Blackstone C (2012) Cellular pathways of hereditary spastic paraplegia. Annu Rev Neurosci 35:25–47. doi:10.1146/annurev-neuro-062111-150400
17. Blumen SC, Bevan S, Abu-Mouch S et al (2003) A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32. Ann Neurol 54:796–803. doi:10.1002/ana.10768
18. Bouhlal Y, Amouri R, El Euch-Fayeche G, Hentati F (2011) Autosomal recessive spastic ataxia of Charlevoix-Saguenay: an overview. Parkinsonism Relat Disord 17:418–422. doi:10.1016/j.parkreldis.2011.03.005
19. Bouhouche A, Benomar A, Bouslam N et al (2006) Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 43:441–443. doi:10.1136/jmg.2005.039230
20. Boukhris A, Stevanin G, Feki I et al (2009) Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. Clin Genet 75(6):527–536. doi:10.1111/j.1399-0004.2009.01176.x
21. Boukhris A, Schule R, Loureiro JL et al (2013) Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet 93:118–123. doi:10.1016/j.ajhg.2013.05.006
22. Bross P, Naundrup S, Hansen J et al (2008) The Hsp60-(p. V98I) mutation associated with hereditary spastic paraplegia SPG13 compromises chaperonin function both in vitro and in vivo. J Biol Chem 283:15694–15700. doi:10.1074/jbc.M800548200
23. Caballero Oteyza A, Battaloğlu E, Ocek L et al (2014) Motor protein mutations cause a new form of hereditary spastic paraplegia. Neurology 82(22):2007–2016. doi:10.1212/WNL.0000000000000479
24. Casari G, De Fusco M, Ciarmatori S et al (1998) Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983
25. Chang J, Lee S, Blackstone C (2014) Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation. J Clin Invest. 124(12):5249–5262. doi:10.1172/JCI77598
26. Citterio A, Arnoldi A, Panzeri E et al (2014) Mutations in CYP2U1, DDHD2 and GBA2 genes are rare causes of complicated forms of hereditary spastic paraparesis. J Neurol 261(2):373–381. doi:10.1007/s00415-013-7206-6
27. Cohen NR, Taylor JS, Scott LB et al (1998) Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol 8:26–33
28. Collongues N, Depienne C, Boehm N et al (2013) Novel SPG10 mutation associated with dysautonomia, spinal cord atrophy, and skin biopsy abnormality. Eur J Neurol 20:398–401. doi:10.1111/j.1468-1331.2012.03803.x
29. Corona P, Lamantea E, Greco M et al (2002) Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann Neurol 51:118–122. doi:10.1002/ana.10059
30. Coutinho P, Barros J, Zemmouri R et al (1999) Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families. Arch Neurol 56:943–949
31. Cremers FP, Pfeiffer RA, van de Pol TJ et al (1987) An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum Genet 77:23–27
32. Crimella C, Baschirotto C, Arnoldi A et al (2012) Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot-Marie-Tooth type 2. Clin Genet 82:157–164. doi:10.1111/j.1399-0004.2011.01717.x
33. Crow YJ, Zaki MS, Abdel-Hamid MS et al (2014) Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. Neuropediatrics 45(6):386–393. doi:10.1055/s-0034-1389161
34. D’Amico A, Tessa A, Sabino A et al (2004) Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology 62:2138–2139
35. Dan P, Edvardson S, Bielawski J, Hama H, Saada A (2011) 2-Hydroxylated sphingomyelin profiles in cells from patients with mutated fatty acid 2-hydroxylase. Lipids Health Dis 10:84. doi:10.1186/1476-511X-10-84
36. Daoud H, Zhou S, Noreau A et al (2012) Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging 33(839):e5–e9. doi:10.1016/j.neurobiolaging.2011.11.012
37. De Bot ST, Schelhaas HJ, Kamsteeg E-J, van de Warrenburg BPC (2012) Hereditary spastic paraplegia caused by a mutation in the VCP gene. Brain J Neurol 135:e223; author reply e224. doi:10.1093/brain/aws201
38. Deluca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30:576–584. doi:10.1111/j.1365-2990.2004.00587.x
39. Deniziak MA, Barciszewski J (2001) Methionyl-tRNA synthetase. Acta Biochim Pol 48:337–350
40. Denton KR, Lei L, Grenier J, Rodionov V, Blackstone C, Li XJ (2014) Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells 32(2):414–423. doi:10.1002/stem.1569
41. Depienne C, Tallaksen C, Lephay JY et al (2006) Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 43:259–265. doi:10.1136/jmg.2005.035311
42. Depienne C, Fedirko E, Forlani S et al (2007) Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet 44:281–284. doi:10.1136/jmg.2006.046425
43. Dick KJ, Eckhardt M, Paisán-Ruiz C et al (2010) Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat 31:E1251–E1260. doi:10.1002/humu.21205
44. Dor T, Cinnamon Y, Raymond L et al (2014) KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction. J Med Genet 51:137–142. doi:10.1136/jmedgenet-2013-102012
45. Dumitrescu AM, Liao X-H, Best TB et al (2004) A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74:168–175. doi:10.1086/380999
46. Dursun U, Koroglu C, Kocasoy Orhan E et al (2009) Autosomal recessive spastic paraplegia (SPG45) with mental retardation maps to 10q24.3-q25.1. Neurogenetics 10:325–331. doi:10.1007/s10048-009-0191-3
47. Ebbing B, Mann K, Starosta A et al (2008) Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet 17:1245–1252. doi:10.1093/hmg/ddn014
48. Edgar JM, McLaughlin M, Yool D et al (2004) Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121–131. doi:10.1083/jcb.200312012
49. Edvardson S, Hama H, Shaag A et al (2008) Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet 83:643–648. doi:10.1016/j.ajhg.2008.10.010
50. Elliott AM, Simard LR, Coghlan G et al (2013) A novel mutation in KIAA0196: identification of a gene involved in Ritscher-Schinzel/3C syndrome in a First Nations cohort. J Med Genet 50:819–822. doi:10.1136/jmedgenet-2013-101715
51. Engert JC, Bérubé P, Mercier J et al (2000) ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 24:120–125. doi:10.1038/72769
52. Erichsen AK, Koht J, Stray-Pedersen A et al (2009) Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 132:1577–1588. doi:10.1093/brain/awp056
53. Erlich Y, Edvardson S, Hodges E et al (2011) Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res 21:658–664. doi:10.1101/gr.117143.110
54. Esteves T, Durr A, Mundwiller E et al (2014) Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia. Am J Hum Genet 94:268–277. doi:10.1016/j.ajhg.2013.12.005
55. Falk J, Bonnon C, Girault J-A, Faivre-Sarrailh C (2002) F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 94:327–334
56. Falk J, Rohde M, Bekhite MM et al (2014) Functional mutation analysis provides evidence for a role of REEP1 in lipid droplet biology. Hum Mutat 35:497–504. doi:10.1002/humu.22521
57. Fassier C, Tarrade A, Peris L et al (2013) Microtubule-targeting drugs rescue axonal swellings in cortical neurons from spastin knockout mice. Dis Model Mech 6:72–83. doi:10.1242/dmm.008946
58. Ferreirinha F, Quattrini A, Pirozzi M et al (2004) Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 113:231–242. doi:10.1172/JCI20138
59. Fink JK (2003) The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 60(8):1045–1049
60. Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol 126(3):307–328. doi:10.1007/s00401-013-1115-8
61. Finsterer J, Löscher W, Quasthoff S et al (2012) Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci 318:1–18. doi:10.1016/j.jns.2012.03.025
62. Füger P, Sreekumar V, Schüle R et al (2012) Spastic paraplegia mutation N256S in the neuronal microtubule motor KIF5A disrupts axonal transport in a Drosophila HSP model. PLoS Genet 8:e1003066. doi:10.1371/journal.pgen.1003066
63. Furukawa Y, Graf WD, Wong H et al (2001) Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56:260–263
64. Ginsberg D, Cruz F, Herschorn S et al (2013) OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology. Adv Ther 30:819–833. doi:10.1007/s12325-013-0054-z
65. Goizet C, Boukhris A, Maltete D et al (2009a) SPG15 is the second most common cause of hereditary spastic paraplegia with thin corpus callosum. Neurology 73:1111–1119. doi:10.1212/WNL.0b013e3181bacf59
66. Goizet C, Boukhris A, Mundwiller E et al (2009b) Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 30:E376–E385. doi:10.1002/humu.20920
67. Goizet C, Depienne C, Benard G et al (2011) REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction. Hum Mutat 32:1118–1127. doi:10.1002/humu.21542
68. Gonzalez M, McLaughlin H, Houlden H et al (2013) Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry 84:1247–1249. doi:10.1136/jnnp-2013-305049
69. Gonzalez-Carmona MA, Sandhoff R, Tacke F et al (2012) Beta-glucosidase 2 knockout mice with increased glucosylceramide show impaired liver regeneration. Liver Int 32:1354–1362. doi:10.1111/j.1478-3231.2012.02841.x
70. Goyal U, Blackstone C (2013) Untangling the web: mechanisms underlying ER network formation. Biochim Biophys Acta 1833:2492–2498. doi:10.1016/j.bbamcr.2013.04.009
71. Hamdan FF, Gauthier J, Araki Y et al (2011) Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88:306–316. doi:10.1016/j.ajhg.2011.02.001
72. Hammer MB, Eleuch-Fayache G, Schottlaender LV et al (2013) Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity. Am J Hum Genet 92:245–251. doi:10.1016/j.ajhg.2012.12.012
73. Hansen JJ, Dürr A, Cournu-Rebeix I et al (2002) Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70:1328–1332. doi:10.1086/339935
74. Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155
75. Harlalka GV, Lehman A, Chioza B et al (2013) Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain 136:3618–3624. doi:10.1093/brain/awt270
76. Hartig MB, Iuso A, Haack T et al (2011) Absence of an orphan mitochondrial protein, C19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet 89:543–550. doi:10.1016/j.ajhg.2011.09.007
77. Hanein S, Durr A, Ribai P et al (2007) A novel locus for autosomal dominant “uncomplicated” hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3. Hum Genet 122:261–273
78. Hanein S, Martin E, Boukhris A et al (2008) Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal recessive spastic paraplegia including Kjellin syndrome. Am J Hum Genet 82:992–1002
79. Hazan J, Fonknechten N, Mavel D et al (1999) Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet 23:296–303. doi:10.1038/15472
80. Heffernan LF, Simpson JC (2014) The trials and tubule-ations of Rab6 involvement in Golgi-to-ER retrograde transport. Biochem Soc Trans 42:1453–1459. doi:10.1042/BST20140178
81. Hehr U, Bauer P, Winner B et al (2007) Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 62:656–665. doi:10.1002/ana.21310
82. Hewamadduma C, McDermott C, Kirby J et al (2009) New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP). Neurogenetics 10:105–110. doi:10.1007/s10048-008-0163-z
83. Hiroko H (2010) Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta 1801:405–414. doi:10.1016/j.bbalip.2009.12.004
84. Hirst J, Borner GHH, Edgar J et al (2013) Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Mol Biol Cell 24(16):2558–2569. doi:10.1091/mbc.E13-03-0170
85. Hodgkinson CA, Bohlega S, Abu-Amero SN et al (2002) A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14. Neurology 59:1905–1909
86. Ilgaz-Aydinlar E, Rolfs A, Serteser M, Parman Y (2014) Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family. Muscle Nerve 49:774–775. doi:10.1002/mus.24145
87. Ishiura H, Sako W, Yoshida M et al (2012) The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet 91:320–329. doi:10.1016/j.ajhg.2012.07.014
88. Ito D, Suzuki N (2009) Seipinopathy: a novel endoplasmic reticulum stress-associated disease. Brain 132:8–15. doi:10.1093/brain/awn216
89. Jouet M, Rosenthal A, Armstrong G et al (1994) X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet 7:402–407. doi:10.1038/ng0794-402
90. Karle KN, Möckel D, Reid E, Schöls L (2012) Axonal transport deficit in a KIF5A(−/−) mouse model. Neurogenetics 13:169–179. doi:10.1007/s10048-012-0324-y
91. Kasher PR, De Vos KJ, Wharton SB et al (2009) Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. J Neurochem 110:34–44. doi:10.1111/j.1471-4159.2009.06104.x
92. Khan TN, Klar J, Tariq M et al (2014) Evidence for autosomal recessive inheritance in SPG3A caused by homozygosity for a novel ATL1 missense mutation. Eur J Hum Genet 22(10):1180–1184. doi:10.1038/ejhg.2014.5
93. Klebe S, Depienne C, Gerber S et al (2012a) Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain 135:2980–2993. doi:10.1093/brain/aws240
94. Klebe S, Lossos A, Azzedine H et al (2012b) KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet 20:645–649. doi:10.1038/ejhg.2011.261
95. Klemm RW, Norton JP, Cole RA et al (2013) A conserved role for atlastin GTPases in regulating lipid droplet size. Cell Rep 3:1465–1475. doi:10.1016/j.celrep.2013.04.015
96. Kruer MC, Paisán-Ruiz C, Boddaert N et al (2010) Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol 68:611–618. doi:10.1002/ana.22122
97. Kurth I, Pamminger T, Hennings JC et al (2009) Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat Genet 41:1179–1181. doi:10.1038/ng.464
98. Landouré G, Zhu P-P, Lourenço CM et al (2013) Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Hum Mutat 34:1357–1360. doi:10.1002/humu.22378
99. Leoni V, Caccia C (2011) Oxysterols as biomarkers in neurodegenerative diseases. Chem Phys Lipids 164:515–524. doi:10.1016/j.chemphyslip.2011.04.002
100. Liguori R, Giannoccaro MP, Arnoldi A et al (2014) Impairment of brain and muscle energy metabolism detected by magnetic resonance spectroscopy in hereditary spastic paraparesis type 28 patients with DDHD1 mutations. J Neurol 261(9):1789–1793. doi:10.1007/s00415-014-7418-4
101. Lin P, Li J, Liu Q et al (2008) A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am J Hum Genet 83:752–759. doi:10.1016/j.ajhg.2008.11.003
102. Lindsey JC, Lusher ME, McDermott CJ et al (2000) Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet 37(10):759–765
103. Liu Y-T, Laurá M, Hersheson J et al (2014) Extended phenotypic spectrum of KIF5A mutations: from spastic paraplegia to axonal neuropathy. Neurology 83:612–619. doi:10.1212/WNL.0000000000000691
104. Lossos A, Stümpfig C, Stevanin G et al (2015) Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia. Neurology 84(7):659–667. doi:10.1212/WNL.0000000000001270
105. Loureiro JL, Brandão E, Ruano L et al (2013) Autosomal dominant spastic paraplegias: a review of 89 families resulting from a Portuguese survey. JAMA Neurol 70:481–487. doi:10.1001/jamaneurol.2013.1956
106. Luo Y, Chen C, Zhan Z et al (2014) Mutation and clinical characteristics of autosomal-dominant hereditary spastic paraplegias in china. Neurodegener Dis 14(4):176–183. doi:10.1159/000365513
107. Macedo-Souza LI, Kok F, Santos S et al (2008) Reevaluation of a large family defines a new locus for X-linked recessive pure spastic paraplegia (SPG34) on chromosome Xq25. Neurogenetics 9:225–226. doi:10.1007/s10048-008-0130-8
108. Magen D, Georgopoulos C, Bross P et al (2008) Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83:30–42. doi:10.1016/j.ajhg.2008.05.016
109. Magré J, Delépine M, Khallouf E et al (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 28:365–370. doi:10.1038/ng585
110. Mannan AU, Krawen P, Sauter SM et al (2006) ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am J Hum Genet 79:351–357. doi:10.1086/504927
111. Martin E, Schüle R, Smets K et al (2013) Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. Am J Hum Genet 92:238–244. doi:10.1016/j.ajhg.2012.11.021
112. McDermott CJ, Dayaratne RK, Tomkins J et al (2001) Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology 56(4):467–471
113. Meijer IA, Hand CK, Cossette P et al (2002) Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch Neurol 59:281–286
114. Meijer IA, Cossette P, Roussel J et al (2004) A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1-10q24.1. Ann Neurol 56:579–582. doi:10.1002/ana.20239
115. Mitne-Neto M, Kok F, Beetz C et al (2007) A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree. Eur J Hum Genet 15(12):1276–1279
116. Montenegro G, Rebelo AP, Connell J et al (2012) Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest 122:538–544. doi:10.1172/JCI60560
117. Moreno-De-Luca A, Helmers SL, Mao H et al (2011) Adaptor protein complex-4 (AP-4) deficiency causes a novel autosomal recessive cerebral palsy syndrome with microcephaly and intellectual disability. J Med Genet 48:141–144. doi:10.1136/jmg.2010.082263
118. Murakami Y, Tawamie H, Maeda Y et al (2014) Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy. PLoS Genet 10:e1004320. doi:10.1371/journal.pgen.1004320
119. Musumeci O, Bassi MT, Mazzeo A et al (2011) A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. Neurol Sci 32:665–668. doi:10.1007/s10072-010-0445-8
120. Neveling K, Martinez-Carrera LA, Hölker I et al (2013) Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy. Am J Hum Genet 92:946–954. doi:10.1016/j.ajhg.2013.04.011
121. Novarino G, Fenstermaker AG, Zaki MS et al (2014) Exome Sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 343:506–511. doi:10.1126/science.1247363
122. Oates EC, Rossor AM, Hafezparast M et al (2013) Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet 92:965–973. doi:10.1016/j.ajhg.2013.04.018
123. Ohmi Y, Tajima O, Ohkawa Y et al (2011) Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem 116:926–935. doi:10.1111/j.1471-4159.2010.07067.x
124. Orlacchio A, Kawarai T, Gaudiello F et al (2005) New locus for hereditary spastic paraplegia maps to chromosome 1p31.1-1p21.1. Ann Neurol 58:423–429. doi:10.1002/ana.20590
125. Orlacchio A, Patrono C, Gaudiello F et al (2008) Silver syndrome variant of hereditary spastic paraplegia: a locus to 4p and allelism with SPG4. Neurology 70:1959–1966. doi:10.1212/01.wnl.0000294330.27058.61
126. Orlacchio A, Babalini C, Borreca A et al (2010) SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133(Pt 2):591–598. doi:10.1093/brain/awp325
127. Orso G, Pendin D, Liu S et al (2009) Homotypic fusion of ER membranes requires the dynamin-like GTPase atlastin. Nature 460:978–983. doi:10.1038/nature08280
128. Orthmann-Murphy JL, Salsano E, Abrams CK et al (2009) Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 132:426–438. doi:10.1093/brain/awn328
129. Oz-Levi D, Ben-Zeev B, Ruzzo EK et al (2012) Mutation in TECPR2 reveals a role for autophagy in hereditary spastic paraparesis. Am J Hum Genet 91:1065–1072. doi:10.1016/j.ajhg.2012.09.015
130. Paisan-Ruiz C, Dogu O, Yilmaz A et al (2008) SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Neurology 70:1384–1389. doi:10.1212/01.wnl.0000294327.66106.3d
131. Park SH, Zhu P-P, Parker RL, Blackstone C (2010) Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER network. J Clin Invest 120:1097–1110. doi:10.1172/JCI40979
132. Patel H, Cross H, Proukakis C et al (2002) SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat Genet 31:347–348. doi:10.1038/ng937
133. Pérez-Brangulí F, Mishra HK, Prots I et al (2014) Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet 23:4859–4874. doi:10.1093/hmg/ddu200
134. Pfeffer G, Gorman GS, Griffin H et al (2014) Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain 137:1323–1336. doi:10.1093/brain/awu060
135. Potter KA, Kern MJ, Fullbright G et al (2011) Central nervous system dysfunction in a mouse model of Fa2h deficiency. Glia 59:1009–1021. doi:10.1002/glia.21172
136. Proukakis C, Moore D, Labrum R, Wood NW, Houlden H (2011) Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males. J Neurol Sci 306(1–2):62–65. doi:10.1016/j.jns.2011.03.043
137. Rahman M, Haberman A, Tracy C et al (2012) Drosophila mauve mutants reveal a role of LYST homologs late in the maturation of phagosomes and autophagosomes. Traffic 13:1680–1692. doi:10.1111/tra.12005
138. Rainier S, Chai J-H, Tokarz D et al (2003) NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet 73:967–971. doi:10.1086/378817
139. Rainier S, Bui M, Mark E et al (2008) Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 82:780–785. doi:10.1016/j.ajhg.2007.12.018
140. Reid E, Dearlove AM, Osborn O et al (2000) A locus for autosomal dominant “pure” hereditary spastic paraplegia maps to chromosome 19q13. Am J Hum Genet 66:728–732
141. Reid E, Kloos M, Ashley-Koch A et al (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71:1189–1194. doi:10.1086/344210
142. Renvoisé B, Stadler J, Singh R et al (2012) Spg20−/− mice reveal multimodal functions for Troyer syndrome protein spartin in lipid droplet maintenance, cytokinesis and BMP signaling. Hum Mol Genet 21:3604–3618. doi:10.1093/hmg/dds191
143. Ribai P, Stevanin G, Bouslam N et al (2006) A new phenotype linked to SPG27 and refinement of the critical region on chromosome. J Neurol 253:714–719. doi:10.1007/s00415-006-0094-2
144. Rismanchi N, Soderblom C, Stadler J et al (2008) Atlastin GTPases are required for Golgi apparatus and ER morphogenesis. Hum Mol Genet 17:1591–1604. doi:10.1093/hmg/ddn046
145. Rivière J-B, Ramalingam S, Lavastre V et al (2011) KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet 89:219–230. doi:10.1016/j.ajhg.2011.06.013
146. Romagnolo A, Masera S, Mattioda A et al (2014) Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation. Eur J Neurol 21:e14–e15. doi:10.1111/ene.12297
147. Rosenthal A, Jouet M, Kenwrick S (1992) Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus. Nat Genet 2:107–112. doi:10.1038/ng1092-107
148. Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174–183. doi:10.1159/000358801
149. Sánchez-Ferrero E, Coto E, Beetz C et al (2013) SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p. A510V. Clin Genet 83(3):257–262. doi:10.1111/j.1399-0004.2012.01896.x
150. Saugier-Veber P, Munnich A, Bonneau D et al (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257–262. doi:10.1038/ng0394-257
151. Schneider SA, Bhatia KP (2010) Three faces of the same gene: FA2H links neurodegeneration with brain iron accumulation, leukodystrophies, and hereditary spastic paraplegias. Ann Neurol 68:575–577. doi:10.1002/ana.22211
152. Schüle R, Bonin M, Dürr A et al (2009a) Autosomal dominant spastic paraplegia with peripheral neuropathy maps to chr12q23-24. Neurology 72:1893–1898. doi:10.1212/WNL.0b013e3181a6086c
153. Schüle R, Schlipf N, Synofzik M et al (2009b) Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry 80:1402–1404. doi:10.1136/jnnp.2008.167528
154. Schüle R, Siddique T, Deng H-X et al (2010) Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. J Lipid Res 51:819–823. doi:10.1194/jlr.M002543
155. Schuurs-Hoeijmakers JHM, Geraghty MT, Kamsteeg E-J et al (2012) Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet 91:1073–1081. doi:10.1016/j.ajhg.2012.10.017
156. Schwartz CE, May MM, Carpenter NJ et al (2005) Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77:41–53. doi:10.1086/431313
157. Sedel F, Fontaine B, Saudubray JM, Lyon-Caen O (2007) Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach. J Inherit Metab Dis 30:855–864. doi:10.1007/s10545-007-0745-1
158. Seri M, Cusano R, Forabosco P et al (1999) Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet 64:586–593. doi:10.1086/302241
159. Shimazaki H, Takiyama Y, Ishiura H et al (2012) A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J Med Genet 49:777–784. doi:10.1136/jmedgenet-2012-101212
160. Shimazaki H, Honda J, Naoi T et al (2014) Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation. J Neurol Neurosurg Psychiatry 85:1024–1028. doi:10.1136/jnnp-2013-306981
161. Simpson MA, Cross H, Proukakis C et al (2003) Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet 73:1147–1156. doi:10.1086/379522
162. Sivakumar K, Sambuughin N, Selenge B et al (1999) Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members. Ann Neurol 45:680–683
163. Słabicki M, Theis M, Krastev DB et al (2010) A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. PLoS Biol 8:e1000408. doi:10.1371/journal.pbio.1000408
164. Spiegel R, Mandel H, Saada A et al (2014) Delineation of C12orf65-related phenotypes: a genotype–phenotype relationship. Eur J Hum Genet 22:1019–1025. doi:10.1038/ejhg.2013.284
165. Starling A, Rocco P, Passos-Bueno MR, Hazan J, Marie SK, Zatz M (2002) Autosomal dominant (AD) pure spastic paraplegia (HSP) linked to locus SPG4 affects almost exclusively males in a large pedigree. J Med Genet 39(12):e77
166. Steinmüller R, Lantigua-Cruz A, Garcia-Garcia R et al (1997) Evidence of a third locus in X-linked recessive spastic paraplegia. Hum Genet 100:287–289. doi:10.1007/s004390050507
167. Stevanin G, Paternotte C, Coutinho P et al (2007a) A new locus for autosomal recessive spastic paraplegia (SPG32) on chromosome 14q12-q21. Neurology 68:1837–1840. doi:10.1212/01.wnl.0000262043.53386.22
168. Stevanin G, Santorelli FM, Azzedine H et al (2007b) Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39:366–372. doi:10.1038/ng1980
169. Stevanin G, Azzedine H, Denora P et al (2008a) Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131:772–784. doi:10.1093/brain/awm293
170. Stevanin G, Ruberg M, Brice A (2008b) Recent advances in the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 8:198–210
171. Svenson IK, Kloos MT, Gaskell PC et al (2004) Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics 5:157–164. doi:10.1007/s10048-004-0186-z
172. Synofzik M, Gonzalez MA, Lourenco CM et al (2014) PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain 137:69–77. doi:10.1093/brain/awt326
173. Takiyama Y (2014) Japan Spastic Paraplegia Research Consortium (JASPAC). Brain Nerve 66(10):1210–1217. doi:10.11477/mf.1416200012
174. Tallaksen CM, Dürr A, Brice A (2001) Recent advances in hereditary spastic paraplegia. Curr Opin Neurol 14:457–463
175. Tamagaki A, Shima M, Tomita R et al (2000) Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. Am J Med Genet 94:5–8. doi:10.1002/1096-8628(20000904)94:1<5::AID-AJMG2>3.0.CO;2-O
176. Tanyel MC, Mancano LD (1997) Neurologic findings in vitamin E deficiency. Am Fam Physician 55:197–201
177. Tarrade A, Fassier C, Courageot S et al (2006) A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet 15:3544–3558. doi:10.1093/hmg/ddl431
178. Tessa A, Silvestri G, de Leva MF et al (2008) A novel KIF5A/SPG10 mutation in spastic paraplegia associated with axonal neuropathy. J Neurol 255:1090–1092. doi:10.1007/s00415-008-0840-8
179. Tesson C, Nawara M, Salih MAM et al (2012) Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet 91:1051–1064. doi:10.1016/j.ajhg.2012.11.001
180. Theofilopoulos S, Griffiths WJ, Crick PJ et al (2014) Cholestenoic acids regulate motor neuron survival via liver X receptors. J Clin Invest 124:4829–4842. doi:10.1172/JCI68506
181. Tiranti V, Corona P, Greco M et al (2000) A novel frameshift mutation of the mtDNA COIII gene leads to impaired assembly of cytochrome c oxidase in a patient affected by Leigh-like syndrome. Hum Mol Genet 9:2733–2742. doi:10.1093/hmg/9.18.2733
182. Tsang HTH, Edwards TL, Wang X et al (2009) The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 18:3805–3821. doi:10.1093/hmg/ddp324
183. Tsaousidou MK, Ouahchi K, Warner TT et al (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 82:510–515. doi:10.1016/j.ajhg.2007.10.001
184. Tucci A, Liu Y-T, Preza E et al (2013) Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry 85:486–492. doi:10.1136/jnnp-2013-306387
185. Uhlenberg B, Schuelke M, Rüschendorf F et al (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus–Merzbacher-like disease. Am J Hum Genet 75:251–260. doi:10.1086/422763
186. Valdmanis PN, Meijer IA, Reynolds A et al (2007) Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet 80:152–161. doi:10.1086/510782
187. Valente EM, Brancati F, Caputo V et al (2002) Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33-q34. Ann Neurol 51:681–685. doi:10.1002/ana.10204
188. Varga R-E, Schüle R, Fadel H et al (2013) Do not trust the pedigree: reduced and sex-dependent penetrance at a novel mutation hotspot in ATL1 blurs autosomal dominant inheritance of spastic paraplegia. Hum Mutat 34:860–863. doi:10.1002/humu.22309
189. Vazza G, Zortea M, Boaretto F et al (2000) A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. Am J Hum Genet 67:504–509. doi:10.1086/303017
190. Verkerk AJMH, Schot R, Dumee B et al (2009) Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 85:40–52. doi:10.1016/j.ajhg.2009.06.004
191. Verny C, Guegen N, Desquiret V et al (2011) Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation. Mitochondrion 11:70–75. doi:10.1016/j.mito.2010.07.006
192. Votsi C, Zamba-Papanicolaou E, Middleton LT et al (2014) A novel GBA2 gene missense mutation in spastic ataxia. Ann Hum Genet 78:13–22. doi:10.1111/ahg.12045
193. Wakil SM, Bohlega S, Hagos S et al (2013) A novel splice site mutation in ERLIN2 causes hereditary spastic paraplegia in a Saudi family. Eur J Med Genet 56:43–45. doi:10.1016/j.ejmg.2012.10.003
194. Wan J, Yourshaw M, Mamsa H et al (2012) Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet 44:704–708. doi:10.1038/ng.2254
195. Wang X, Shaw WR, Tsang HTH et al (2007) Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nat Neurosci 10:177–185. doi:10.1038/nn1841
196. Wang X, Yang Y, Wang X, Li C, Jia J (2014) A novel KIAA0196 (SPG8) mutation in a Chinese family with spastic paraplegia. Chin Med J (Engl) 127(10):1987–1989
197. Watts GDJ, Wymer J, Kovach MJ et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381. doi:10.1038/ng1332
198. Wedding IM, Koht J, Tran GT et al (2014) Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. PLoS One 9:e86340. doi:10.1371/journal.pone.0086340
199. Werner HB, Krämer-Albers E-M, Strenzke N et al (2013) A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia 61:567–586. doi:10.1002/glia.22456
200. Windpassinger C, Auer-Grumbach M, Irobi J et al (2004) Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 36:271–276. doi:10.1038/ng1313
201. Yao D, McGonigal R, Barrie JA et al (2014) Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. J Neurosci 34:880–891. doi:10.1523/JNEUROSCI.3996-13.2014
202. Yıldırım Y, Orhan EK, Iseri SAU et al (2011) A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contractures. Hum Mol Genet 20:1886–1892. doi:10.1093/hmg/ddr070
203. Zanni G, Scotton C, Passarelli C et al (2013) Exome sequencing in a family with intellectual disability, early onset spasticity, and cerebellar atrophy detects a novel mutation in EXOSC3. Neurogenetics 14:247–250. doi:10.1007/s10048-013-0371-z
204. Zhao X, Alvarado D, Rainier S et al (2001) Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326–331. doi:10.1038/ng758
205. Zhao G, Hu Z, Shen L et al (2008) A novel candidate locus on chromosome 11p14.1-p11.2 for autosomal dominant hereditary spastic paraplegia. Chin Med J (Engl) 121:430–434
206. Zhu P-P, Denton KR, Pierson TM et al (2014) Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A. Hum Mol Genet 23:5638–5648. doi:10.1093/hmg/ddu280
207. Zivony-Elboum Y, Westbroek W, Kfir N et al (2012) A founder mutation in Vps37A causes autosomal recessive complex hereditary spastic paraparesis. J Med Genet 49:462–472. doi:10.1136/jmedgenet-2012-100742
208. Zöller I, Meixner M, Hartmann D et al (2008) Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci 28:9741–9754. doi:10.1523/JNEUROSCI.0458-08.2008
209. Zortea M, Vettori A, Trevisan CP et al (2002) Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1. J Med Genet 39:387–390
210. Züchner S, Wang G, Tran-Viet K-N et al (2006) Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 79:365–369. doi:10.1086/505361